参考文献/References:
[1] 陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10.
Chen WQ, Zhang SW, Zeng HM,et al.Report of cancer incidence andmortality in China,2010[J].China Cancer,2014,23(1):1-10.
[2] 于 晨,孙秀华,赵金波,等.晚期非小细胞肺癌预后因素的回顾性研究[J].中华临床医师杂志(电子版),2011,5(9):2691-2696.
Yu C, Sun XH, Zhao JB,et al.The Retrospective study of advancednon-small cell lung cancer prognostic factors[J].Chinese Journal of Clinicians(Electronic Edition),2011,5(9):2691-2696.
[3] National Cancer Institute(us). Non-small cell lung cancer treatment(PDQ),health professional version[EB/OL].http//www.ncbi.nlm.nih.gov/pubmed/26820032,2002.
[4] 王 静,李峻岭.晚期非小细胞肺癌患者的凝血功能分析[J].中国肿瘤临床及康复,2012,19(2):139-141.
Wang J,Li JL.The analysis of coagulative function in patients withadvanced-non-small cell lung cancer[J].Chinese Journal of Clinical Oncology and Rehabilitation,2012,19(2):139-141.
[5] Hiroaki K, Hirofumi U, Yujiyo A,et al.Analysis of tissue factor and tissue factor pathway inhibit or expression in human colorectal carcinoooma celllines and metastatic sublines to the liver[ J].Int J Cancer,1997,72(5):878-884.
[6] Palumbo JS,Potter JM,Kaplan LS,et al.Spontaneo-us hematogenous and lymphatic metastasis,but not primary tumor growth or angiogenesis,is diminishedin fibrinogen-deficient mice[J].Cancer Research,2002,62(23):6966-6972.
[7] Zietemann V,Duell T.Every-day clinical practice in patients with advanced non-small-cell lung cancer[J].Lung Cancer,2010,68(2):273-277.
[8] Aliustaoglu M,Bilici A,Seker M,et al.The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer[J].Hepato-gastrocnterology,2010,57(99/100):640-645.
[9] Raungkaewmanee S, Tangjitgamol S, Manusirivitha-ya S,et al.Plateletto lymphocyte ratio as a prognostic factor for epithelial ovarian cancer[J].Journal of Gynecoogic Oncology,2012,23(4):265-273.
[10] Kwon HC,Kim SH,Oh SY,et al.Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer[J].Biomarkers,2012,17(3):216-222.
[11] Tomita M,Shimizu T,Ayabe T,et al.Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small celllung cancer[J].Anticancer Res,2011,31(9):2995-2998.
[12] Dutta S,Crumley AB,Fullarton GM,et al.Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of oesophageal cancer[J].World J Surg,2011,35(8):1861-1866.
相似文献/References:
[1]薛鸿涛,任 敏,李长彬.非小细胞肺癌患者放疗前后血清TSGF和CRP的变化及其临床意义[J].现代检验医学杂志,2016,31(02):136.[doi:10.3969/j.issn.1671-7414.2016.02.041]
XUE Hong-tao,REN Min,LI Chang-bin.Impact and Clinical Significance of Radiotherapy on Serum
TSGF and CRP in Patients with Non Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):136.[doi:10.3969/j.issn.1671-7414.2016.02.041]
[2]王京伟,李 艳,童永清,等.湖北地区非小细胞肺癌EGFR 基因突变及其意义的研究[J].现代检验医学杂志,2016,31(03):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
WANG Jing-wei,LI Yan,TONG Yong-qing,et al.Detection of Epidermal Growth Factor Receptor(EGFR)
Mutations and the Significance in Patients with Non-small Cell Lung
Cancer(NSCLC)of Hubei Province[J].Journal of Modern Laboratory Medicine,2016,31(02):7.[doi:10.3969/j.issn.1671-7414.2016.03.003]
[3]易甲其,范艳平,周宁加,等.血清PTX-3,CYFRA21-1和TPS在非小细胞肺癌中的变化及临床意义[J].现代检验医学杂志,2015,30(05):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
YI Jia-qi,FAN Yan-ping,ZHOU Ning-jia,et al.Changes and Clinical Significance of Serum PTX-3,
CYFRA21-1,TPS in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2015,30(02):58.[doi:10.3969/j.issn.1671-7414.2015.05.018]
[4]钱忠萍,凌 晨,祁松楠,等.围非小细胞肺癌手术期T细胞含量变化的研究[J].现代检验医学杂志,2016,31(05):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
QIAN Zhong-ping,LING Chen,QI Song-nan,et al.Content Variation of T Cells in Perioperative Patients
with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):55.[doi:10.3969/j.issn.1671-7414.2016.05.014]
[5]黎谢梦丹,罗 凯,吴顺芳,等.华南地区非小细胞肺癌患者肿瘤组织EGFR,ALK和ROS1基因突变分析[J].现代检验医学杂志,2017,32(05):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
LIXIE Meng-dan,LUO Kai,WU Shun-fang,et al.Mutation Analysis of EGFR,ALK and ROS1 in Tumor Tissues
of Patients with Non-Small Cell Lung Cancer in South of China[J].Journal of Modern Laboratory Medicine,2017,32(02):16.[doi:10.3969/j.issn.1671-7414.2017.05.005]
[6]李小龙,白巧艳,陆婉玲.老年非小细胞肺癌患者低分割放疗对凝血功能的影响[J].现代检验医学杂志,2018,33(05):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
LI Xiao-long,BAI Qiao-yan,LU Wan-ling.Influence of Hypofractionated High-Dose Radiotherapy on Coagulation Function in Elderly Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):142.[doi:10.3969/j.issn.1671-7414.2018.05.039]
[7]郭 华a,齐宗利a,张海祥b,等.非小细胞肺癌组织EGFR/ALK/ROS1基因联合检测的临床意义[J].现代检验医学杂志,2018,33(06):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
GUO Huaa,QI Zong-lia,ZHANG Hai-xiangb,et al.Clinical Significance of Combined Detection of EGFR/ALK/ROS1 Genes in Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):17.[doi:10.3969/j.issn.1671-7414.2018.06.005]
[8]黄 刚,陈 霏,肇玉博,等.非小细胞肺癌患者血浆miRNA-145和miRNA-221表达与临床特征及术后复发的相关性研究[J].现代检验医学杂志,2019,34(04):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
HUANG Gang,CHEN Fei,ZHAO Yu-bo,et al.Study on the Correlation between the Expression of MicroRNA145
and MicroRNA221 in Plasma and Clinical Characteristics and
Postoperative Recurrence in Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2019,34(02):40.[doi:10.3969/j.issn.1671-7414.2019.04.010]
[9]蒋玲丽,黄中强,王雪亮,等.表皮生长因子受体(EGFR)基因突变检测质控品制备及应用[J].现代检验医学杂志,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]
JIANG Ling-li,HUANG Zhong-qiang,WANG Xue-liang,et al.Development and Application of Quality Control Materials for EpidermalGrowth Factor Receptor (EGFR)Mutation Determination[J].Journal of Modern Laboratory Medicine,2020,35(02):145.[doi:10.3969/j.issn.1671-7414.2020.02.040]
[10]彭 琦a,程少鹏b,陈辅萍a.非小细胞肺癌组织中NSE 的基因表达及与患者临床特征的相关性研究[J].现代检验医学杂志,2020,35(03):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]
PENG Qia,CHENG Shao-pengb,CHEN Fu-pinga.Correlation between NSE Gene Expression and Serum NSE Level in Tumor Tissues
and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer[J].Journal of Modern Laboratory Medicine,2020,35(02):36.[doi:10.3969/j.issn.1671-7414.2020.03.008]